Order Article Reprints

Rogmans C, Kuhlmann JD, Hugendieck G, Link T, Arnold N, Weimer JP, Flörkemeier I, Rambow A-C, Lieb W, Maass N, et al. ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer. Cancers. 2021; 13(21):5563. https://doi.org/10.3390/cancers13215563

Rogmans, Christoph, Jan Dominik Kuhlmann, Gerrit Hugendieck, Theresa Link, Norbert Arnold, Jörg Paul Weimer, Inken Flörkemeier, Anna-Christina Rambow, Wolfgang Lieb, Nicolai Maass, and et al. 2021. "ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer" Cancers 13, no. 21: 5563. https://doi.org/10.3390/cancers13215563

Rogmans, C., Kuhlmann, J. D., Hugendieck, G., Link, T., Arnold, N., Weimer, J. P., Flörkemeier, I., Rambow, A. -C., Lieb, W., Maass, N., Bauerschlag, D. O., & Hedemann, N. (2021). ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer. Cancers, 13(21), 5563. https://doi.org/10.3390/cancers13215563